Cj Cheiljedang Corporation

Bong Joon Kim

Heon Woong Jung

Kwang Woo Hwang

Tae Joon Won

Kang-Pyo Lee

Jin Hee Lee

Kang Pyo Lee

Sae Hun Kim

Tae Hoon Chun

Se Hee Hwang

Tae Jin Kim

Sung Hun Kim

Kyung Min Lee

Hee-yeon Kim

Yoon Tack Jang

Ho Jin Moon

Ji Hoon Koh

So Young Kim

Gi Duk Bae

Byoung Seok Moon

Young Mee Chung

Min-Jeong Kim

Seo Hyung Woo

Jie Eun Park

Kyu Yeol Son

Ji-Young Oh

Sang Hyun Seo

Min-Soo Kwon

Jae Ho Jang

Hyun Sun Yun

Taejoon Won

Hee Yoon Ahn

Da Hye Jeong

A method for treating an immune disease caused by a Th1/Th2 imbalance in favor of a Th2 shift in a subject including administering a composition comprisingCJLP133 strain KCTC 11403BP to the subject in need thereof.

and composition comprising same

CJLP243 (KCTC 11045P), a composition for treating intestinal diseases comprisingCJLP243, and a composition for enhancing immune response comprisingCJLP243.

and composition comprising the same

The present disclosure relates to a novelCJLP475 strain having acid-resistance, bile-resistance and an immune-enhancing activity, and a composition including the same.

CJLP475 strain having antiviral and immunomodulatory effects and composition comprising the same

The present disclosure relates to a composition comprising aCJLP475 strain deposited under Accession No. KCCM12287P; and aCJLP243 strain deposited under Accession No. KCCM11045P, and use thereof.

Composition comprisingCJLP475 strain andCJLP243 strain and use thereof

The present invention providesCJLP133 KCTC 11403BP, a composition for treating intestinal diseases comprising the lactic acid bacteria, and a composition for enhancing immunity comprising the lactic acid bacteria.

[object Object]

The present invention relates toCJGN34 KCTC 10974BP lactic acid bacteria, fermented foods including kimchi manufactured using the lactic acid bacteria as a starter, and lactic acid bacteria composition comprising of the lactic acid bacteria. The novelCJGN34 of the present invention enhances the general taste quality of kimchi; increases the intrinsic complex sour taste and carbonated taste of kimchi manufactured by traditional manufacturing method in wintertime; and regularly sustains the fermentation quality during the year; particularly, has an effect for controlling the deterioration of fermentation quality in the summer in which the taste quality deteriorates. Thus, the lactic acid bacteria of the present invention can be used as a starter in fermented foods including kimchi, or as a drug medicine in the form of a tablet or capsule mixed with carriers or additives, or a s probiotics for foods; or applied in cosmetic ingredients by mixing in a certain amount. Therefore, the lactic acid bacteria of the present invention can be used in a manner commonly applied in various fields of technology such as medicine, food, feed, cosmetics or the like.

The present invention providesCJLP55 KCTC 11401BP, a composition for treating bowel disease containing the, and a composition for immunological enhancement containing the

Growing community of inventors

Incheon, South Korea

Bong Joon Kim